An IRG prognostic signature including SLC10A2, FGF2, CCL28, NDRG1, ESM1, UCN, UTS2 and TRDC was constructed which showed moderate predictive ability for the overall survival of CRC patients in both the training and validation sets. This evidence concerns the gene FGF2 and colorectal carcinoma.